These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9164675)

  • 1. William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer.
    Katzenellenbogen BS; Montano MM; Ekena K; Herman ME; McInerney EM
    Breast Cancer Res Treat; 1997 May; 44(1):23-38. PubMed ID: 9164675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
    Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
    Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
    Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
    J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
    Jordan VC
    Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic guide to the mechanisms of antiestrogen action.
    MacGregor JI; Jordan VC
    Pharmacol Rev; 1998 Jun; 50(2):151-96. PubMed ID: 9647865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
    Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK
    Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
    Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
    Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.
    Zhang X; Ding L; Kang L; Wang ZY
    PLoS One; 2012; 7(1):e30174. PubMed ID: 22276155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens.
    Suba Z
    Recent Pat Anticancer Drug Discov; 2017; 12(2):136-147. PubMed ID: 28245776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells.
    Scafoglio C; Ambrosino C; Cicatiello L; Altucci L; Ardovino M; Bontempo P; Medici N; Molinari AM; Nebbioso A; Facchiano A; Calogero RA; Elkon R; Menini N; Ponzone R; Biglia N; Sismondi P; De Bortoli M; Weisz A
    J Cell Biochem; 2006 Aug; 98(5):1163-84. PubMed ID: 16514628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
    Montano MM; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351.
    Levenson AS; MacGregor Schafer JI; Bentrem DJ; Pease KM; Jordan VC
    J Steroid Biochem Mol Biol; 2001; 76(1-5):61-70. PubMed ID: 11384864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of antiestrogen action in breast cancer.
    Jordan VC
    Breast Cancer Res Treat; 1994; 31(1):41-52. PubMed ID: 7981455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
    Montano MM; Jaiswal AK; Katzenellenbogen BS
    J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.
    Jiang SY; Wolf DM; Yingling JM; Chang C; Jordan VC
    Mol Cell Endocrinol; 1992 Dec; 90(1):77-86. PubMed ID: 1301400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.